Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension

Viatris

Status and phase: Completed; Phase 3

Conditions: Ocular Hypertension; Glaucoma, Open Angle

Treatments: Drug: unfixed Latanoprost and Timolol; Drug: Xalacom

Study type: Interventional

Funder types: Industry

Identifiers

NCT00219596

A6641028

Details and patient eligibility

About

to compare efficacy and safety of Xalacom with the combination of unfixed Latanoprost and Timolol in subjects with open-angel glaucoma or ocular hypertension

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with open-angle glaucoma or ocular hypertension

Exclusion criteria

• closed/barely open anterior chamber angle or a history of acute angel closure glaucoma
• Ocular surgery within 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)